NuroTone Medical
Optical Cochlear Implant
StartupNuroTone Medical is a Rosh Haayin-based startup in the Health Tech & Life Sciences sector, established in 2018. Optical Cochlear Implant. NuroTone Medical was founded by Yossi Bornstein, Danny Albeck, Prof. Claus Richter. The company has 1-10 employees. Core technologies: Materials & Substances, Implants, Sensing, Acoustics, Laser.
The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StagePre-Funding
- ProductR&D
- ModelB2B
- Employees1-10
- HQRosh Haayin
- DistrictCenter District
- Last RoundUndisclosed
Yossi BornsteinCo-founder & Chairman
Danny AlbeckCo-founder & CEO
Prof. Claus RichterCo-founder & CSO
What does NuroTone Medical do?
NuroTone is developing a cochlear implant based on precise light stimulation of cochlear neurons, overcoming the inherent limitations of existing basic cochlear implant technology and products. NuroTone uses precise laser stimulation of cochlear neurons to improve speech recognition and music perception, reduce sensitivity to environmental noise, and reduce efforts of daily hearing and training.
Who founded NuroTone Medical?
NuroTone Medical was founded in 2018 by Yossi Bornstein (Co-founder & Chairman), Danny Albeck (Co-founder & CEO), Prof. Claus Richter (Co-founder & CSO).
What sector is NuroTone Medical in?
NuroTone Medical operates in Health Tech & Life Sciences, Medical Devices, Assistive Devices, with core technologies in Materials & Substances, Implants, Sensing, Acoustics, Laser. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Patients.
Where is NuroTone Medical located?
NuroTone Medical is based in HaMelacha Street 10, Rosh Haayin, Israel, Center District.